Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 158.80
-1.40 (-0.87%)
At close: Jun 19, 2026
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 210.48 billion as of June 22, 2026. Its market cap has decreased by -23.01% in one year.
Market Cap
210.48B
Enterprise Value
253.67B
Revenue
88.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
158.80
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has decreased from 226.73B to 210.48B, a decrease of -7.17%. That is a compound annual growth rate of -2.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 210.48B | -7.96% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 557.17B |
| GlaxoSmithKline Pharmaceuticals | 395.20B |
| J. B. Chemicals & Pharmaceuticals | 351.51B |
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |
| Granules India | 194.73B |
| Caplin Point Laboratories | 190.50B |
| Jubilant Pharmova | 152.96B |